techcrunch.com
AI isn’t close to curing cancer. This startup says it knows what it will take.
A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a machine to fix it. The company's autonomous biology labs can grow 20 kinds of human tissue, then autonomously dose and monitor them, generating the kind of ca…